FDA approves new technology to study coronavirus

Techcrunch notes that the department’s initiative may be related to criticism of government

institutions in the country that are slow to acceptsolutions despite the widespread spread of coronavirus. According to them, “officials were not prepared to effectively counter the spread of the new virus in the country, despite the fact that they were aware of the potential risks.”

Now, research centers in the US cantry to use new technologies that they think can counteract the virus. To do this, they will not have to wait for the approval of the FDA, which in some cases can be obtained within a few months.

Harmful emissions in China have dropped sharply. Scientists have linked this to coronavirus

Techcrunch also notes that the US Centers forUntil the end of February 2020, only 459 trials of similar technologies were carried out for the control and prevention of diseases. For comparison, in China this figure is five times higher. In addition, the country did not have enough tests - many of them contained a faulty reagent.

“We believe that our policy providesthe right balance during this public health emergency, the FDA said. “We will help ensure that scientific evidence is valid before clinical trials and subsequent critical independent testing by the FDA, while rapidly expanding US testing capabilities.”